Cancer #drugshortage ongoing crisis in the U.S. Platinum chemo critical to maintain high cure rate for #germcelltumors. See asco.org/drug-shortages for continued guidance from ASCO, most recently updated to include #testiscancer (joining bladder, breast, GI, Gyn, H&N, SCLC...)

#DrugShortages Update for Cisplatin: ⚠️ Apotex/Qilu has 10 batches available. Call: 800-706-5575 ⚠️ FDA-approved manufacturer, Gland Pharma Limited, will have a new supply starting the 3rd week of July, from their distributor, Sagent. Call: 866-625-1618

We’re accepting comments on our draft guideline, "Systemic Therapy in Men with Metastatic Castration-Resistant #ProstateCancer." Submit feedback to us by July 31: fal.cn/3zXtQ #pcsm

❗❗ Read our clinical guidance for #ovarian cancer #germcell tumors during the current #drugshortages. Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin #gyncsm

🎙️Podcast🎙️ Listen in as we discuss the updated #GeriatricAssessment #Guidelines and the new Practical #GeriatricAssessment from ASCO with William Dale, MD, PhD, FASCO @rochgerionc Heidi Klepin Brittany Harvey sites.libsyn.com/115284/ascogui… #PracticalGA23 #OncoAlert #GeriOnc #OlderAdults #Cancer

Now available: guideline update on practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: fal.cn/3zYJ1 #GeriOnc #SuppOnc

A new ASCO study, co-led by the HICCC's Dr. Dawn Hershman (Dawn Hershman) has been awarded $11 million in research funding by The Patient-Centered Outcomes Research Institute to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer. Columbia Medicine old-prod.asco.org/about-asco/pre…

#DrugShortages update for CARBOplatin: Ingenus Pharmaceuticals now has 450 mg/45mL (10 mg/mL) available. For more information contact Ingenus team at 866-321-5031.

❕ We’ve issued a rapid guideline update on the management of stage III #NSCLC: fal.cn/3A3XJ #lcsm

Thank u Jacqueline Howard & CNN for focusing on how the chemo shortage will impact current-and potentially future—patients. Clinical trials are being impacted at many cancer centers. SGO & ASCO continuing our efforts to help patients & work with Congress & U.S. FDA on solutions.

‼️ New clinical guidance available for #mesothelioma during the current #drugshortages. Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin

‼️ New clinical guidance available for #NSCLC during the current #drugshortages #lcsm Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin.

🚨 Check out what’s popular this week in #JCO: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update ➡️ fal.cn/3AhrC William Dale, MD, PhD, FASCO @rochgerionc Cristiane D Bergerot Vanita Noronha, MBBS MD DM #gerionc

Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments JCO Oncology Practice OncoAlert Journal of Clinical Oncology Julie Gralow Clifford Hudis Unfortunately, it is still real and we need to be vigilant about how continue to optimize treatment for our patients ascopubs.org/doi/10.1200/OP…

Great collaborating with Edgardo S. Santos, M.D., FACP, FASCO, Dr. Cathy Eng, Amanda Nickles Fader, MD, Tom Oliver, Christina Lacchetti & Lalan Wilfong to produce guidance on treating pts during antineoplastic drug shortages for JCO Oncology Practice. 15 chemo drugs currently in shortage. ascopubs.org/doi/full/10.12…

This week we’re calling attention to the continued #drugshortage crisis and working to inform policymakers of the deeply distressing circumstance patients are facing. Learn more and tell Congress to act now: brnw.ch/21wF0ok #ASCOAdvocacy #OncTwitter

New resource-stratified guideline on systemic treatment of patients with metastatic #BreastCancer ➡️ brnw.ch/21wG1VH #bcsm #mBC

Our members are sending a clear message to policymakers: cancer #drugshortages have gone on for too long, and we need solutions now. Add your voice and sign our Open Letter: brnw.ch/21wITOO #ASCOAdvocacy

A cancer #drugshortage "is not a problem that will fix itself through the power of the markets,” explains ASCO member Jason Westin, MD FACP FASCO. Sign our Open Letter urging policymakers to act now to find solutions that will end this crisis: brnw.ch/21wJd5z #ASCOAdvocacy

One of the most moving slides I’ve seen at an oncology conference👇🏻 I’ve often found survival curves to be sobering & dispassionate in equal measure, each declivity a nameless loss But even when we have a 0% success rate at rendering patients immortal this is what they live FOR